Metformin Accord

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Accord (Metformin Hydrochloride)

Q: What is Metformin Accord used for?

Metformin Accord is an oral antihyperglycaemic medication indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body's response to insulin and reducing hepatic glucose production.

Q: How does Metformin work in the body?

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses liver glucose output and enhances insulin‑mediated glucose uptake in muscle. This dual action lowers fasting and post‑prandial blood glucose without directly stimulating insulin secretion.

Q: What is the usual dose of Metformin Accord?

The dosage of Metformin Accord is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Q: Is Metformin safe during pregnancy or breastfeeding?

Metformin may be used during pregnancy only if clearly needed and prescribed by a healthcare professional. Limited data exist for breastfeeding; the decision should be made by the prescriber after weighing potential benefits against possible risks to the infant.

Q: How do I order Metformin Accord from GNH India?

To place an order, submit an enquiry on the Metformin Accord product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Q: How does Metformin compare with other oral antidiabetic drugs?

Metformin is a first‑line biguanide that improves insulin sensitivity and has a low risk of hypoglycaemia compared with sulfonylureas or meglitinides. Unlike some newer agents, it is inexpensive, weight‑neutral, and has a well‑established safety profile, making it a preferred initial therapy for many patients.

Q: What are the recommended storage conditions for Metformin Accord?

Metformin Accord should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Q: How is Metformin Accord administered?

Metformin Accord is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformin?

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Q: Who should not use Metformin Accord?

Metformin is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in patients receiving iodinated contrast agents for imaging studies unless renal function is re‑evaluated afterward.

Metformin, the active ingredient in Metformin Accord, is a Biguanide presented as a tablet for oral use. It is employed to improve blood glucose control in adults with type 2 diabetes mellitus, often as part of a comprehensive lifestyle and pharmacologic regimen.

GNH India supplies Metformin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution with robust regulatory support.

Manufacturer / TM Owner

Accord Healthcare Polska Sp. Z O.O.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Accord belongs to the biguanide class and is used to manage disorders of glucose metabolism.

Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels.
Prediabetes: helps delay progression to overt diabetes when combined with diet and exercise.
Polycystic ovary syndrome (PCOS): may improve insulin resistance and restore ovulatory function.

How It Works

Metformin reduces hepatic gluconeogenesis and increases peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). This leads to decreased glucose production in the liver and enhanced glucose uptake in muscle, while also modestly reducing intestinal glucose absorption, collectively improving overall blood glucose homeostasis.

Side Effects

Metformin is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

Nausea: mild to moderate stomach upset.
Diarrhoea: frequent loose stools.
Abdominal discomfort: cramping or pain.
Metallic taste: transient alteration of taste perception.
Loss of appetite: reduced desire to eat.
Flatulence: increased intestinal gas.

Serious or Rare Side Effects

Lactic acidosis: rare but potentially fatal metabolic disturbance.
Severe hypoglycaemia: when combined with other glucose‑lowering agents.
Vitamin B12 deficiency: may develop with long‑term use.
Hepatic dysfunction: elevated liver enzymes.
Skin rash or hypersensitivity reactions.
Pancreatitis: inflammation of the pancreas.

Precautions & Warnings

Metformin should be used with careful clinical assessment and monitoring.

Renal function assessment: avoid in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic disease: use cautiously in patients with liver dysfunction.
Cardiovascular status: monitor in patients with heart failure.
Alcohol consumption: limit intake to reduce lactic acidosis risk.
Blood glucose monitoring: adjust therapy based on glycaemic response.
Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Metformin may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

Iodinated contrast media: can precipitate acute renal failure, increasing lactic acidosis risk.
Cimetidine: may raise metformin plasma concentrations.
Trimethoprim: can reduce renal clearance of metformin.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycaemia symptoms.
ACE inhibitors or ARBs: monitor renal function and potassium levels.
Warfarin: may enhance anticoagulant effect, requiring INR checks.
Digoxin: increased risk of gastrointestinal upset.

Frequently Asked Questions

Metformin Accord is an oral antihyperglycaemic medication indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body's response to insulin and reducing hepatic glucose production.

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses liver glucose output and enhances insulin‑mediated glucose uptake in muscle. This dual action lowers fasting and post‑prandial blood glucose without directly stimulating insulin secretion.

The dosage of Metformin Accord is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Metformin may be used during pregnancy only if clearly needed and prescribed by a healthcare professional. Limited data exist for breastfeeding; the decision should be made by the prescriber after weighing potential benefits against possible risks to the infant.

To place an order, submit an enquiry on the Metformin Accord product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Metformin is a first‑line biguanide that improves insulin sensitivity and has a low risk of hypoglycaemia compared with sulfonylureas or meglitinides. Unlike some newer agents, it is inexpensive, weight‑neutral, and has a well‑established safety profile, making it a preferred initial therapy for many patients.

Metformin Accord should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Metformin Accord is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in patients receiving iodinated contrast agents for imaging studies unless renal function is re‑evaluated afterward.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.